#clinical trials

Collection of clinical trials news, found 401 news.

Microbiome leader Prof. Borody at China FMT Conference calls for investment in Faecal Transplant Clinical Trials to fight serious diseases

Microbiome leader Prof. Borody at China FMT Conference calls for investment in Faecal Transplant Clinical Trials to fight serious diseases

  • 18th May 2017

A future where faecal transplants in China will cure conditions like autism, IBD, arthritis, Parkinson's disease and ...

Latest clinical research confirms that IQOS reduces smoker exposure to select harmful chemicals as compared to cigarette smoke

Latest clinical research confirms that IQOS reduces smoker exposure to select harmful chemicals as compared to cigarette smoke

  • 27th March 2017

- Philip Morris International Inc. (PMI) (NYSE/Euronext Paris: PM) today announces the positive results from an ...

New Frost & Sullivan research reveals Asia as Preferred Destination for Clinical Trials

New Frost & Sullivan research reveals Asia as Preferred Destination for Clinical Trials

  • 3rd March 2017

Frost & Sullivan today released its latest white paper, 'Asia: Preferred Destination for Clinical Trials', with ...

LFB S.A. announced today the acceptance by U.S. Food and Drug Administration of the filed Biologic License Application for Coagulation Factor VIIa Recombinant, (eptacog beta activated)

LFB S.A. announced today the acceptance by U.S. Food and Drug Administration of the filed Biologic License Application for Coagulation Factor VIIa Recombinant, (eptacog beta activated)

  • 9th January 2017

- LFB S.A., announced that its Biologic License Application (BLA), requesting marketing approval of ...

AGC signs agreement for acquisition of leading biopharmaceutical CDMO, CMC Biologics

AGC signs agreement for acquisition of leading biopharmaceutical CDMO, CMC Biologics

  • 22nd December 2016

-AGC Asahi Glass ("AGC"), a world-leading manufacturer of glass, chemicals and high-tech materials, announced on ...

Ancillare announces new Vice President of Asia-Pacific

Ancillare announces new Vice President of Asia-Pacific

  • 7th December 2016

- Ancillare, LP, the leader in end-to-end global clinical trial ancillary supply chain ...

Biden announces U.S. project to promote cancer data sharing

Biden announces U.S. project to promote cancer data sharing

  • 7th June 2016

U.S. Vice President Joe Biden said  the "moonshot" initiative he leads aimed at finding cures for cancer was "the ...

Study reveals Glutathione’s role in combating Non-Alcoholic Fatty Liver Disease (NAFLD)

Study reveals Glutathione’s role in combating Non-Alcoholic Fatty Liver Disease (NAFLD)

  • 7th May 2016

- The results of a recent multi-center clinical study show, for the first time, that oral administration ...

Samsung Bioepis' Flixabi® Infliximab biosimilar recommended for approval in the European Union

Samsung Bioepis' Flixabi® Infliximab biosimilar recommended for approval in the European Union

  • 2nd April 2016

- Samsung Bioepis Co., Ltd. today announced that the European Medicines Agency’s (EMA) Committee for Medicinal ...

Mitsubishi Tanabe Pharma Corporation signs licensing agreement with A. Menarini Asia-Pacific for Spedra (Avanafil) in 10 countries in Asia-Pacific

Mitsubishi Tanabe Pharma Corporation signs licensing agreement with A. Menarini Asia-Pacific for Spedra (Avanafil) in 10 countries in Asia-Pacific

  • 27th February 2016

- Mitsubishi Tanabe Pharma Corporation (TSE: 4508), and Singapore-based A. Menarini Asia-Pacific Holdings Pte Ltd ...

Treatment results of SIR-Spheres® Y-90 resin microspheres are similar regardless of patient age, new publication shows

Treatment results of SIR-Spheres® Y-90 resin microspheres are similar regardless of patient age, new publication shows

  • 3rd February 2016

-606-patient MORE Study Sub-Group Analysis Examined Outcomes for Elderly (≥70 years) and Very Elderly (≥75 ...

Samsung Bioepis enters the European biopharmaceutical market with Benepali®, the first fusion protein biosimilar approved by the European Commission

Samsung Bioepis enters the European biopharmaceutical market with Benepali®, the first fusion protein biosimilar approved by the European Commission

  • 18th January 2016

- Samsung Bioepis Co., Ltd. today announced the European Commission’s (EC) approval of Benepali® – a ...

ASX-listed Holista and Swiss bakery ingredients specialist Veripan announce breakthrough formulae to produce clean-label white bread with lowest glycemic index (GI)

ASX-listed Holista and Swiss bakery ingredients specialist Veripan announce breakthrough formulae to produce clean-label white bread with lowest glycemic index (GI)

  • 12th January 2016

- Australian-listed Holista CollTech Limited (ASX: HCT) announced today a global scientific breakthrough, validated ...

Samsung Bioepis' RENFLEXIS® Infliximab Biosimilar Receives Regulatory Approval in Korea

Samsung Bioepis' RENFLEXIS® Infliximab Biosimilar Receives Regulatory Approval in Korea

  • 4th December 2015

- Samsung Bioepis Co., Ltd. today announced that Korea’s Ministry of Food and Drug Safety (MFDS) has approved ...

Merck and Pfizer Collaborate with Dako, an Agilent Technologies Company, on Development of Companion Diagnostic for Investigational anti-PD-L1 Antibody, Avelumab

Merck and Pfizer Collaborate with Dako, an Agilent Technologies Company, on Development of Companion Diagnostic for Investigational anti-PD-L1 Antibody, Avelumab

  • 25th September 2015

based companion diagnostic (CDx) in immuno-oncologyDARMSTADT, Germany & NEW YORK--(Antara/BUSINESS WIRE.